<<

Solid phase synthesis (SPPS), strategies, resins and comparison with Fmoc-strategy General scheme of SPPS

attach to linker

deprotect amino function

couple

n times deprotection and coupling cleave N-α-protecting groups

• two mainly used N-α-protecting groups

Fmoc Boc Boc-

Boc = tert. Butyloxycarbonyl or tert. Butoxycarbonyl

stable to bases and unaffected by catalytic deprotection with TFA is rapid Introduction of the Boc-group

Di-tert-butyl-dicarbonate 2-(tert. Butoxycarbonyl-

= Boc-anhydride = (t-boc)2O oxyimino)-2-phenylacetonitril = Boc-NO

O O O O O O O O N

N

• both commercially available • storage in refrigerator for extended periods

•(t-boc)2O is more expensive • preparation: „Kates S. A., Albericio F. (ed): Solid-Phase Synthesis, A practical guide, Marcel Dekker Inc. 2000, p. 105-107“ N-α-Boc protected amino acids

•alreadyN-α-Boc protected amino acids can simply be bought from firms like „Novabiochem“

O e.g. Boc-Ala-OH O N COOH H Cleavage of the Boc-group

TFA

E1-elimination

CO2 cleavage

TFA is volatile and can be easily removed in vacuum! Resins for Boc SPPS  Resins for preparing peptide acids

 Merrifield (Chloromethylstyrene-divinylbenzene) - was the standard support for the synthesis of peptide acids by Boc SPPS - now only used in the synthesis of small to medium sized , because the benzylic resin linkage is not completely stable towards repetitive treatment with TFA O H Cl , DMF N boc O - + + BocAS Cs ,KI R

- attachment of the C-terminal residue is achieved by heating the resin in DMF with the appropiate cesium salt in the presence of KI - cleavage is affected by treatment of resin with HF or TFMSA, or by hydrogenolysis

- alcohols can be released using reducing agents like DIBALH or LiBH4 - methyl can be produced by transesterification with NaOMe Resins for Boc SPPS  Resins for preparing peptide acids

 PAM (4-Hydroxymethylphenylacetamidomethyl) - also a standard support for Boc SPPS - stabilizing effect of the phenylacetamidomethyl function on the ester linkage  reduction of losses during repetitive TFA acidolysis

O H N boc O O R N coupling: H a) first addition of the PAM-linker on to the aminomethyl resin and then coupling of the Boc-protected amino acid b) first coupling of the Boc-protected amino acid to the PAM-linker and then reaction with the aminomethyl resin followed by end-capping of unreacted aminomethyl groups cleavage: - treatment with HF or TFMSA releases the peptide acid Resins for Boc SPPS  Resins for preparing peptide acids

 Brominated Wang (Brominated α-Methylphenylacyl resin)

O R O Br , DMF boc O N + BocAS-Cs+,KI H O

hν (350 nm)

O H N boc OH R Resins for Boc SPPS  Resins for preparing peptide

 BHA / MBHA (Benzhydrylamine / 4-Methylbenzhydrylamine) - used for the synthesis of peptide amides by Boc SPPS - attachment of the first amino acid with standard methods of bond formation - cleavage of the carboxamides with HF or TFMSA - MBHA is more acid sensitive and the peptide amide can be released with HF or TFMSA under less drastic conditions

NH2 NH2 Resins for Boc SPPS  Resins for preparing C-terminally modified peptide fragments

 Brominated PPOA (Brominated [4-Propionylphenoxy]-) - versatile resin for the Boc SPPS of peptide acids, esters and hydrazides by photolytic or nucleophilic cleavage

O O O O N , DMF O N H H H Br - + N + BocAS Cs ,KI boc O O R O

ν h or NaOH in NEt3 in NH2NH2/ dioxane methanol/ DMF dioxane

O O O H H H N N N NH boc O boc OMe boc N 2 H R R R Resins for Boc SPPS  Resins for preparing C-terminally modified peptide fragments

 Oxime resin - attachment of the first amino acid with DCC - afterwards acetylation of unreacted oxime groups

- cleavage from the support by various nucleophiles like NaOH, NH3, R1NH2, NaBH4, MeOH, NH2NH2

NO 2 NO2

amino acid, DCC H HO N O N R N O General aspects of Boc strategy

• cleavage of the N-α-Boc-protection group with TFA (usually 25-50% (v/v) in DCM) • side chain protecting groups must be orthogonal(!), that means: • stable against TFA during N-α-Boc deprotection • removable at the end of • release of the peptide from the resin by treatment with HF Side chain protecting groups for Boc strategy

Arg: Toluolsulfonyl- (Tos) or Mesitylen-2-sulfonyl-group (Mts) cleavage: HF/anisole (Tos) thioanisole (Mts) Ser, Thr, Tyr: Benzyl (Bzl) O cleavage: HF R

Asp, Glu: Bzl boc N COOH H O O O H Lys: Fmoc or Cl O N H OH O N O HN 2-Chlorobenzyloxycarbonyl (2ClZ) boc OH HN cleavage: (Fmoc), TFA (2ClZ) boc

O S Cys: Acetamidomethyl (Acm) or OH MeO NH 4-Methoxybenzyl (MeOBzl) boc cleavage: Hg2+-or Ag+-salts (Acm), HF (MeOBzl)

His: Dinitrophenyl-group (DNP) cleavage: thioles DNP Advantages and disadvantages of Boc- and Fmoc-strategy

Advantages Boc Disadvantages  easy to introduce  temporary and permanent (side chain)   Boc-amino acids are stable at room protecting groups are both acid labile side chain deprotection during repeated temp. for extended periods (but TFA treatment can occur storage at 4°C is recommended)  repeated TFA-mediated N-α-deprotection  deprotection with TFA is rapid over the course of a long synthesis may  successful strategy for many peptide lead to modification and/or degradation of synthesis applications sensitive peptide sequences   good coupling results difficulties for fragile peptides that don‘t survive the relatively harsh final HF cleavage  Boc-strategy requires the use of “dangerous“ HF and expensive laboratory apparates  side reactions are possible: t-Bu+ reacts with nucleophilic side chains like trp, tyr, met, his  side chain protecting groups / adding of scavengers (1,2-Ethanedithiole) to the deprotection reagent Advantages and disadvantages of Boc- and Fmoc-strategy Fmoc Advantages Disadvantages

 orthogonal protection sheme  Piperidine: harmful vapor, toxic  Fmoc-amino acids are easy to  side reactions: prepare in crystalline form in high • aspartimide formation at Asp- and stable when stored at 4°C X residues like Asp-Gly, -Ser,  milder reaction conditions: -Thr, -Asn, -Gln milde base (piperidine) for N-α • linker-bound C-terminal Cys deprotection, TFA only for the final undergoes significant resin cleavage and deprotection racemisation (ca. 0,5%) with  progress of each deprotection each cycle of Piperidine- reaction can be followed by real time treatment spectrophotometric monitoring the release of the cleaved Fmoc-group at 300-320 nm Literature

-Novabiochem 2002/3 Catalog -www.cup.unimuenchen.de/oc/carell/lehre/peptide2.pdf -Kates S. A., Albericio F. (ed): Solid-Phase Synthesis, A practical guide, Marcel Dekker Inc. 2000